Hypouricemic effects of phenylpropanoid glycosides acteoside of Scrophularia ningpoensis on serum uric acid levels in potassium oxonate-pretreated mice

American Journal of Chinese Medicine

Volumn 36, Issue 1, 2008, Pages 149-157

  Huang, Cai Guo ^a   Shang, Yan Jun ^b   Zhang, Jun ^b   Zhang, Jian Rong ^b   Li, Wen Jie ^b   Jiao, Bin Hua ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hyperuricemia, Hypouricemic Action; Phenylpropanoid Glycoside Acteoside; Xanthine Dehydrogenase; Xanthine Oxidase

Indexed keywords

ACTEOSIDE; ALLOPURINOL; GLYCOSIDE; OXONATE POTASSIUM; URIC ACID; XANTHINE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; EXTRACTION; HYPERURICEMIA; MALE; MOUSE; NONHUMAN; SCROPHULARIA NINGPOENIS; SCROPHULARIACEAE; URIC ACID BLOOD LEVEL;

ANIMALS; GLYCOSIDES; HYPERURICEMIA; MALE; MICE; MICE, INBRED ICR; OXONIC ACID; PLANT EXTRACTS; PLANT ROOTS; SCROPHULARIA; URIC ACID; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 44049102529     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X08005667     Document Type: Article

References (33)

1. Boss, G.R. and J.E. Seegmiller. Hyperuricemia and gout. Classification, complications and management. N. Engl. J. Med. 300: 1459-1468, 1979.
2. Burkhardt, S., R.J. Reiter, D.X. Tan, R. Hardeland, J. Cabrera and M. Karbownik. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Cell Biol. 33: 775-783, 2001.
3. Calis, I., G.A. Gross and O. Sticher. Phenylpropanoid glycosides isolated from Scrophularia scopolii. Phytochemistry 26: 2057-2061, 1987.
4. Carroll, J.J., H. Coburn, R. Douglass and A.L. Babson. A simplified alkaline phosphotungstate assay for uric acid in serum. Clin. Chem. 17: 158-160, 1971.
5. Chen, G.L. and S.Y. Xu. The progress of study on hyperuricemia. Chin. Pharmacol. Bull. 19: 1082-1092, 2003.
6. Chiang, H.C., Y.J. Lo and F.J. Lu. Xanthine oxidase inhibitors from the leaves of Alsophila spinulosa (Hook) Tryon. J. Enzyme Inhib. 8: 61-71, 1994.
7. Duck, J.A. and E. Agensu. Medical Plants of China. Reference Publications Inc., Algonac, Michigan, 1985.
8. Fang, J. and M.H. Alderman. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 283: 2404-2410, 2000.
9. Fritsch, P.O. and A. Sidoroff. Drug-induced Stevens-Johnson syndrome/ toxic epidermal necrolysis. Am. J. Clin. Dermatol. 1: 349-360, 2000.
10. Gurwitz, J.H., S.C. Kalish, R.L. Bohn, R.J. Glynn, M. Monane, H. Mogun and J. Avorn. Thiazide diuretics and the initiation of anti-gout therapy. J. Clin. Epidemiol. 50: 953-959, 1997.
11. Hall, I.H., J.P. Scoville, D.J. Reynolds, R. Simlot and P. Duncan. Substituted cyclic imides as potential anti-gout agents. Life Sci. 46: 1923-1927, 1990.
12. Hammer, B., A. Link, A. Wagner and M. Bohm. Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch. Med. Wochenschr 126: 1331-1334, 2001.
13. Horiuchi, H., M. Ota, S. Nishimura, H. Kaneko, Y. Kasahara, T. Ohta and K. Komoriya. Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice. Life Sci. 66: 2051-2070, 2000.
14. Ishibuchi, S., H. Morimoto, T. Oe, T. Ikebe, H. Inoue, A. Fukunari, M. Kamezawa, I. Yamada and Y. Naka. Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. Bioorg. Med. Chem. Lett. 11: 879-882, 2001.
15. Kong, L., J. Zhou, Y. Wen, J. Li and C.H. Cheng. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/ dehydrogenase inhibitory activity. Planta Med. 68: 175-178, 2002.
16. Kong, L.D., C. Yang, F. Ge, H.D. Wang and Y.S. Guo. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol. 93: 325-330, 2004.
17. Kramer, H.M. and G. Curhan. The association between gout and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988-1994. Am. J. Kidney Dis. 40: 37-42, 2002.
18. Li, Y., J. Stamler, Z. Xiao, A. Folsom, S. Tao and H. Zhang. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int. J. Epidemiol. 26: 288-296, 1997.
19. Li, Y.M., S.H. Jiang, W.Y. Gao and D.Y. Zhu. Phenylpropanoid glycosides from Scrophularia ningpoensis. Phytochemistry 54: 923-925, 2000.
20. Liese, A.D., H.W. Hense, H. Lowel, A. Doring, M. Tietze and U. Keil. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 10: 391-397, 1999.
21. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
22. Nguyen, M.T., S. Awale, Y. Tezuka, L. Shi, S.F. Zaidi, J.Y. Ueda, Q.L. Tran, Y. Murakami, K. Matsumoto and S. Kadota. Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Biol. Pharm. Bull. 28: 2231-2234, 2005.
23. Oettl, K. and G. Reibnegger. Pteridines as inhibitors of xanthine oxidase: Structural requirements. Biochim. Biophys. Acta 1430: 387-395, 1999.
24. Osada, Y., M. Tsuchimoto, H. Fukushima, K. Takahashi, S. Kondo, M. Hasegawa and K. Komoriya. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur. J. Pharmacol. 241: 183-188, 1993.
25. Owen, P.L. and T. Johns. Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J. Ethnopharmacol. 64: 149-160, 1999.
26. Pereira, S., J. Almeida, A.O. Silva, M. Quintas, O. Candeias and F. Freitas. Fatal liver necrosis due to allopurinol. Acta Med. Port. 11: 1141-1144, 1998.
27. Puddu, P.E., M. Lanti, A. Menotti, M. Mancini, A. Zanchetti, M. Cirillo, M. Angeletti and W. Panarelli. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study. Acta Cardiol. 56: 243-251, 2001.
28. Singh, S., S. Farhan Asad and S.M. Hadi. Uric acid inhibits L-DOPA-CU(II) mediated DNA cleavage. Neurosci. Lett. 258: 69-72, 1998.
29. Stavric, B., S. Clayman, R.E. Gadd and D. Hebert. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol. Res. Commun. 7: 117-124, 1975.
30. Tomita, M., S. Mizuno, H. Yamanaka, Y. Hosoda, K. Sakuma, Y. Matuoka, M. Odaka, M. Yamaguchi, H. Yosida, H. Morisawa and T. Murayama. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J. Epidemiol. 10: 403-409, 2000.
31. Wang, Y., J.X. Zhu, L.D. Kong, C. Yang, C.H. Cheng and X. Zhang. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic Clin. Pharmacol. Toxicol. 94: 232-237, 2004.
32. Zhao, X., J.X. Zhu, S.F. Mo, Y. Pan and L.D. Kong. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J. Ethnopharmacol. 103: 357-365, 2006.
33. Zhou, C.X., L.D. Kong, W.C. Ye, C.H. Cheng and R.X. Tan. Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense. Planta Med. 67: 158-161, 2001.